한빛사논문
- 조회1,350
Young-Chan Kwon1,†, Keith Meyer1, Guangyong Peng1,2, Soumya Chatterjee1,2, Daniel F Hoft1,2 and Ranjit Ray1,2,*
1Departments of Internal Medicine, Saint Louis University, Missouri, USA
2Molecular Microbiology & Immunology, Saint Louis University, Missouri, USA
†Present address : The Scripps Research Institute, Florida
*To whom correspondence may be addressed.
Abstract
A comprehensive strategy to control HCV infection needs a vaccine. Our phase I study with recombinant HCV E1/E2 EnvGPs as a candidate vaccine did not induce a strong immune response in volunteers. We analyzed the interactions of HCV EnvGPs with human monocyte derived macrophages as antigen presenting cells. HCV E2 induced immune regulatory cytokine IL-10 and sCD163 protein expression in macrophages from 7 of 9 blood donors tested. Further, HCV E2 enhanced Stat3 and suppressed Stat1 activation, reflecting macrophage polarization towards M2 phenotype. E2 associated macrophage polarization appeared to be dependent of its interaction with CD81 leading EGFR activation. Additionally, E2 suppressed the expression of C3 complement, similar to HCV exposed dendritic cells, implying potential impairment of immune cell priming.
Conclusion: Our results suggest that E2 EnvGP may not be an ideal candidate for HCV vaccine development, and discrete domains within E2 may prove to be more capable of elliciting a protective immune response. This article is protected by copyright. All rights reserved.
Keywords:Hepatitis C virus; E2 envelope glycoprotein; antigen presenting cells; transcription factors; immunity
논문정보
- Research article
- 2018년 02월 (BRIC 등록일 2018-03-05)
- 국외 연구진
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
연구자 ID
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기
